SAShinji Akamine

Shinji Akamine

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shinji Akamine has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Induction Chemotherapy with Cisplatin, Vinorelbine, and Mitomycin-C Followed by Surgery for Patients with Pathologic N2 Non–Small-Cell Lung Cancer

    by Shinji Akamine, Yoichi Nakamura, Tadayuki Oka, Hiroshi Soda, Hideki Taniguchi, Masaaki Fukuda, Hiroyuki Minami, Seiji Nagashima, Kazuto Ashizawa, Tomoyuki Goya, et al.


  • Open Access

    Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer

    by Masashi Muraoka, Shinji Akamine, Tadayuki Oka, Tsutomu Tagawa, Akihiro Nakamura, Tomoshi Tsuchiya, Tomayoshi Hayashi, Takeshi Nagayasu

    Objective: It is controversial whether a systematic mediastinal lymph node dissection (MLND) needs to be performed in all patients with stage I lung cancer. The present study was done to examine the new sentinel lymph nodes hypothesis based on the lobe of the primary tumor. Methods: In our first study, the lymph node (LN) metastases were assessed in 291 stage I non-small cell lung cancer (NSCLC) patients who had a major lung resection with a systematic mediastinal lymph node dissection. We evaluated the validity of using our new sentinel lymph nodes method based on the lobe of the primary tumor as follows: the pretracheal (#3), tracheobronchial (#4), and hilar nodes (#10) for right upper lobe tumors; #4, subcarinal (#7), and #10 for middle lobe tumors; the subaortic (#5), paraaortic (#6), and #10 for left upper lobe tumors; and the #7, #10, and interlobar nodes (#11) for tumors in either lower lobes. In the second study, we performed a lobectomy with new sentinel node sampling in 64 patients with preoperative complications. If all of the sampling nodes showed no metastases on frozen section diagnosis, systematic node dissections were not performed. Results: Six of 291 patients in the first study had skip metastases that did not involve the new sentinel nodes; 5 of the 6 patients had macroscopic pleural invasion. Thus, we defined pleural invasion as an exclusion criterion for the second study. In the second study, the median follow-up time was 39 months. Metastatic lymph nodes were detected in 11 of 64 patients. Fifty-three patients (83%) had no metastasis in the sampled nodes, and, therefore, a mediastinal lymph node dissection was not done. The morbidity rate in the sampling group was 36%, and there was no mortality. In the sampling group, local recurrences were observed in two patients, distant metastases in eight, and carcinomatous pleuritis in one; the overall 5-year survival rate was 82%. Conclusions: We found that it is possible to perform a less invasive lymphadenectomy for patients with stage I lung cancer using intra-operative sampling of new sentinel lymph nodes.


  • Open Access

    Surgical Treatment for Multiple Primary Lung Cancer

    by Masashi Muraoka, Tadayuki Oka, Shinji Akamine, Tsutomu Tagawa, Satoshi Hashizume, Keitaro Matsumoto, Yutaka Tagawa, Tomayoshi Hayashi, Takeshi Nagayasu

    目的. 多発肺癌に対する外科治療成績を検討し, 手術適応と術式選択につき検討する. 対象と方法. 臨床病理学的に多発肺癌と診断した64例を対象とした. 結果. 平均年齢64.3歳, 男女比49:15, 同時性27, 異時性37例. 組織型は共に腺癌27, 共に扁平上皮癌14, 腺癌―扁平上皮癌11例で, 病期は共にI期35, I・II期14例. 同時性では一期的手術14例, 二期的手術11例で, 複数回手術43例の初回手術は肺葉切除 (27例) が多く, 2回目は縮小手術が多かった (28例). 4例に両側肺葉切除, 3例に残存肺全摘術を行った. 術死および重篤な術後合併症は認めなかった. 予後は異時性が術後5年生存率 (5生率) 74.9%, 同時性は63.9%であった. 異時性で二次癌がIA期では5生率85.1%, IB期で66.7%, II期以上は有意に予後不良であった. 組織型では共に腺癌 (81.5%) が最も良好であった. 結論. 多発肺癌に対する外科治療は合併症も少なく安全に施行できた. 二次癌に対しても, 残存肺機能やperformance statusがよい症例には, 両側肺葉切除や残存肺全摘術も可能である. 特にI期症例では予後も期待でき, 積極的に外科治療を行うべきである.


  • Open Access

    Thoracoscopic drainage with wound edge protector for descending necrotizing mediastinitis

    by Takeshi Nagayasu, Shinji Akamine, Tadayuki Oka, Masashi Muraoka

    It has recently been found that wide recognition of descending necrotizing mediastinitis (DNM) and its resultant early diagnosis can reduce the high mortality rate associated with this disease by allowing for rapid surgical intervention. Nevertheless, thoracotomy remains controversial as a treatment for DNM. We report a successful case of DNM in which the mediastinitis had spread below the carina and which was treated by drainage through cervicotomy and by thoracoscopic drainage with mini-thoracotomy using the newly available wound edge protector called a Lap-protector.


  • THE EFFECT OF THE PLATELET-ACTIVATING FACTOR INHIBITOR TCV-309 ON REPERFUSION INJURY IN A CANINE MODEL OF ISCHEMIC LUNG

    by Katsunobu Kawahara, Tsutomu Tagawa, Takao Takahashi, Shinji Akamine, Akihiro Nakamura, Satoru Yamamoto, Seiji Muraoka, Masao Tomita


  • FOUR CASES OF CHYLOTHORAX FOLLOWING THORACOTOMY

    by Shigehiko Itoh, Hisakuni Ohe, Shinji Akamine, Noboru Tokuyama, Osamu Soeda, Yuusuke Nakano, Hideki Taniguchi, Naoyuki Tujino, Masao Tomita